## Clinical Diagnosis This patient has **primary osteoarthritis (OA) of both knees** with typical features: insidious onset, morning stiffness, pain on activity, bony enlargement (Heberden/Bouchard nodes equivalent in knees), crepitus, and radiological confirmation (joint space narrowing, osteophytes, subchondral sclerosis). ## Management Algorithm for Symptomatic OA ```mermaid flowchart TD A[Symptomatic OA confirmed]:::outcome --> B[Non-pharmacological interventions]:::action B --> C[Weight reduction + Physiotherapy + Topical NSAIDs]:::action C --> D{Adequate relief?}:::decision D -->|Yes| E[Continue conservative care]:::action D -->|No| F[Add intra-articular injection]:::action F --> G[Corticosteroid or Hyaluronic acid]:::action G --> H{Functional improvement?}:::decision H -->|Yes| I[Maintain + Reassess]:::action H -->|No| J[Consider surgical intervention]:::action J --> K[Total knee arthroplasty]:::action ``` ## Rationale for Intra-articular Corticosteroid Injection **Key Point:** Intra-articular corticosteroid injection is the most appropriate next step when conservative measures (oral/topical NSAIDs, weight loss, physiotherapy) provide inadequate symptom control. - **Mechanism:** Reduces local inflammation, synovial fluid volume, and pain; provides 3–6 weeks of relief in 60–70% of patients [cite:Campbell's Orthopedic Surgery 13e Ch 42] - **Timing:** Indicated when conservative therapy fails but patient is not yet a surgical candidate - **Combination approach:** Injection + physiotherapy + weight reduction offers synergistic benefit - **Evidence:** Cochrane reviews support intra-articular corticosteroids for short-term pain relief in knee OA **Clinical Pearl:** Limit intra-articular corticosteroid injections to 3–4 per joint per year to avoid cartilage damage from repeated injections. **High-Yield:** The stepwise approach is: (1) conservative (weight loss, physio, topical NSAIDs), (2) intra-articular injection, (3) surgery. This patient has exhausted step 1 partially and is ready for step 2. ## Why This Patient Is Not Yet a Surgical Candidate - Modest functional limitation (not severe disability) - Relatively young (62 years old) - Bilateral disease (staged approach preferred) - No mention of failed conservative therapy over adequate duration ## Comparison of Intra-articular Options | Feature | Corticosteroid | Hyaluronic Acid | | --- | --- | --- | | Onset of action | 3–7 days | 2–4 weeks | | Duration of relief | 3–6 weeks | 3–6 months | | Mechanism | Anti-inflammatory | Viscosupplementation | | Cost | Lower | Higher | | Frequency | Up to 4/year | 3–5 injections per course | | Evidence strength | Strong (short-term) | Moderate (variable) | | First-line role | Yes, when conservative fails | Second-line or adjunct | **High-Yield:** Corticosteroid is preferred as the next step because it offers faster onset and is more cost-effective in the Indian healthcare context. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.